{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:38:29Z","timestamp":1773401909023,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T00:00:00Z","timestamp":1104364800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00262-004-0584-y","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T00:14:41Z","timestamp":1104365681000},"page":"424-430","source":"Crossref","is-referenced-by-count":97,"title":["Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn"],"prefix":"10.1007","volume":"54","author":[{"given":"Ella","family":"Kagan","sequence":"first","affiliation":[]},{"given":"Govind","family":"Ragupathi","sequence":"additional","affiliation":[]},{"given":"San San","family":"Yi","sequence":"additional","affiliation":[]},{"given":"Celso A.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Jeff","family":"Gildersleeve","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Kahne","sequence":"additional","affiliation":[]},{"given":"Henrik","family":"Clausen","sequence":"additional","affiliation":[]},{"given":"Samuel J.","family":"Danishefsky","sequence":"additional","affiliation":[]},{"given":"Philip O.","family":"Livingston","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2004,12,30]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1200\/JCO.1994.12.5.1036","volume":"12","author":"PO Livingston","year":"1994","unstructured":"Livingston PO, Wong GYC, Adluri S, Tao Y, Padavan M, Parente R, Hanlon C, Helling F, Ritter G, Oettgen HF, Old LJ (1994) Improved survival in AJCC stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol 12:1036?1044","journal-title":"J Clin Oncol"},{"key":"CR2","first-page":"874","volume":"6","author":"PB Chapman","year":"2000","unstructured":"Chapman PB, Morrissey DM, Panageas KS, Hamilton WB, Zhan C, Destro AN, Williams L, Israel RJ, Livingston PO (2000) Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-KLH+QS21 vaccine: a dose-response study. Clin Cancer Res 6:874?879","journal-title":"Clin Cancer Res"},{"key":"CR3","first-page":"197","volume":"54","author":"F Helling","year":"1994","unstructured":"Helling F, Shang Y, Calves M, Oettgen HF, Livingston PO (1994) Increased immunogenicity of GD3 conjugate vaccines: comparison of various carrier proteins and selection of GD3-KLH for further testing. Cancer Res 54:197?203","journal-title":"Cancer Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<659::AID-IJC11>3.0.CO;2-5","volume":"85","author":"G Ragupathi","year":"2000","unstructured":"Ragupathi G, Meyers M, Adluri S, Howard L, Musselli C, Livingston PO (2000) Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21. Int J Cancer 85:659?666","journal-title":"Int J Cancer"},{"key":"CR5","first-page":"2773","volume":"5","author":"MN Dickler","year":"1999","unstructured":"Dickler MN, Ragupathi G, Liu NX, Musselli C, Martino DJ, Miller VA, Kris MG, Brezicka FT, Livingston PO, Grant SC (1999) Immunogenicity of the fucosyl-GM1-keyhole limpet hemocyanin (KLH) conjugate vaccine in patients with small cell lung cancer. Cancer Res 5:2773?2779","journal-title":"Cancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1521-3773(19990215)38:4<563::AID-ANIE563>3.0.CO;2-3","volume":"38","author":"G Ragupathi","year":"1999","unstructured":"Ragupathi G, Slovin S, Adluri S, Sames D, Kim IJ, Kim HM, Spassova M, Bornmann WG, Lloyd K, Scher HI, Livingston PO, Danishefsky SJ (1999) A fully synthetic globo H carbohydrate vaccine induces a focused humoral response in prostate cancer patients: a proof of principle. Angewandte Chemie 38:563?566","journal-title":"Angewandte Chemie"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.051626298","volume":"98","author":"T Gilewski","year":"2001","unstructured":"Gilewski T, Ragupathi G, Bhuta S, Williams LJ, Musselli C, Zhang XF, Bencsath KP, Panageas KS, Chin J, Norton L, Houghton AN, Livingston PO et al (2001) Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A 98:3270?3275","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/1097-0215(20000701)87:1<79::AID-IJC12>3.0.CO;2-L","volume":"87","author":"P Sabbatini","year":"2000","unstructured":"Sabbatini P, Kudryashov V, Ragupathi G, Danishefsky S, Livingston PO, Bornmann W, Spassova M, Spriggs D, Aghajanian C, Soignet S, Peyton M, O?Flaherty C et al (2000) Immunization of ovarian cancer patients with a synthetic LewisY?protein conjugate vaccine: clinical and serological results. Int J Cancer 87:79?85","journal-title":"Int J Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/sj.bjc.6990288","volume":"79","author":"S Adluri","year":"1999","unstructured":"Adluri S, Gilewski T, Zhang S, Ramnath V, Ragupathi G, Livingston PO (1999) Specificity analysis of sera from breast cancer patients vaccinated with Muc1-KLH plus QS-21. Br J Cancer 79:1806?1812","journal-title":"Br J Cancer"},{"key":"CR10","first-page":"1693","volume":"6","author":"T Gilewski","year":"2000","unstructured":"Gilewski T, Adluri S, Ragupathi G, Zhang S, Yao TJ, Panageas K, Moynahan M, Houghton A, Norton L, Livingston PO (2000) Vaccination of high risk breast cancer patients with Mucin-1 keyhole limpet hemocyanin conjugate plus QS-21. Clin Cancer Res 6:1693?1701","journal-title":"Clin Cancer Res"},{"key":"CR11","first-page":"3364","volume":"55","author":"S Zhang","year":"1995","unstructured":"Zhang S, Walberg LA, Ogata S, Itzkowitz SH, Koganty RR, Reddish M, Gandhi SS, Longenecker BM, Lloyd KO, Livingston PO (1995) Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen. Cancer Res 55:3364?3368","journal-title":"Cancer Res"},{"key":"CR12","first-page":"1572","volume":"16","author":"M Dicker","year":"1997","unstructured":"Dicker M, Gilewski T, Ragupathi G, Adluri R, Koganty RR, Longenecker M, Houghton AN, Norton L, Livingston PO (1997) Vaccination of breast cancer patients (pts) with no evidence of disease (NED) with sialyl Tn cluster (sTa(c))-keyhole limpet hemocyanin (KLH) conjugate plus adjuvant QS-21: preliminary results. Proc ASCO 16:1572","journal-title":"Proc ASCO"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1073\/pnas.90.6.2495","volume":"90","author":"H Nakada","year":"1993","unstructured":"Nakada H, Inoue M, Numata Y, Tanaka N, Funakoshi J, Fukui S, Mellors A, Yamashina I (1993) Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128). Proc Natl Acad Sci U S A 90:2495?2499","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002620050542","volume":"48","author":"G Ragupathi","year":"1999","unstructured":"Ragupathi G, Howard L, Cappello S, Koganty RR, Qiu D, Longenecker BM, Reddish MA, Lloyd KO, Livingston PO (1999) Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl) cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells. Cancer Immunol Immunother 48:1?8","journal-title":"Cancer Immunol Immunother"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.274.5292.1520","volume":"274","author":"R Liang","year":"1996","unstructured":"Liang R, Yan L, Loebach J, Ge M, Uozumi Y, Sekanina K, Horan N, Gildersleeve J, Thompson C, Smith A, Biswas K, Still WC et al (1996) Parallel synthesis and screening of a solid phase carbohydrate library. Science 274:1520?1522","journal-title":"Science"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"10554","DOI":"10.1073\/pnas.94.20.10554","volume":"94","author":"R Liang","year":"1997","unstructured":"Liang R, Loebach J, Horan N, Ge M, Thompson C, Yan L, Kahne D (1997) Polyvalent binding to carbohydrates immobilized on an insoluble resin. Proc Natl Acad Sci U S A 94:10554?10559","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1006936826730","volume":"15","author":"G Ragupathi","year":"1998","unstructured":"Ragupathi G, Koganty RR, Qui DS, Lloyd KO, Livingston PO (1998) A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn KLH conjugate using a 4-(4-N-maleimidomethyl)cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm. Glycoconjugate J 15:217?221","journal-title":"Glycoconjugate J"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"24156","DOI":"10.1074\/jbc.270.41.24156","volume":"270","author":"T White","year":"1995","unstructured":"White T, Bennett EP, Takio K, Sorensen T, Bonding N, Clausen H (1995) Purification and cDNA cloning of a human UDP-N-acetyl-?-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. J Biol Chem 270:24156?24165","journal-title":"J Biol Chem"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"30472","DOI":"10.1074\/jbc.273.46.30472","volume":"273","author":"EP Bennett","year":"1998","unstructured":"Bennett EP, Hassan H, Mandel U, Mirgorodskaya EP, Burchell J, Taylor-Papadimitriou J, Hollingsworth MA, Merkx G, Vankessel AG, Eiberg H, Steffensen R, Clausen H (1998) Cloning of a human UDP-N-acetyl-alpha-D-alactosaminepolypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. J Biol Chem 273:30472?30481","journal-title":"J Biol Chem"},{"key":"CR20","first-page":"3315","volume":"56","author":"S Zhang","year":"1996","unstructured":"Zhang S, Graeber LA, Helling F, Ragupathi G, Adluri S, Lloyd KO, Livingston PO (1996) Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice. Cancer Res 56:3315?3319","journal-title":"Cancer Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0003-2697(03)00041-1","volume":"316","author":"JS Rohrer","year":"2003","unstructured":"Rohrer JS, Miller HI (2003) Detecting O-linked oligosaccharides on glycoproteins. Anal Biochem 316:131?134","journal-title":"Anal Biochem"},{"key":"CR22","first-page":"4036","volume":"54","author":"S Ogata","year":"1994","unstructured":"Ogata S, Chen A, Itzkowitz SH (1994) Use of model cell lines to study the biosynthesis and biological role of cancer-associated sialosyl-Tn antigen. Cancer Res 54:4036?4044","journal-title":"Cancer Res"},{"key":"CR23","unstructured":"Huntsberger DV, Leaverton PE (ed) (1970) In: Statistical inference in the biomedical sciences. Allyn Bacon, Boston, pp 138?140, 337?338"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1016\/S0021-9258(18)68365-6","volume":"263","author":"A Kurosaka","year":"1988","unstructured":"Kurosaka A, Kitagawa H, Fukui S, Numata Y, Nakada H, Fuakoshi I, Kawasaki T, Ogawa T, Iijima H, Yamashina I (1988) A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAc?2?6GalNAc, in mucin-type glycoproteins. J Biol Chem 263:8724?8726","journal-title":"J Biol Chem"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-004-0584-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0584-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T01:21:38Z","timestamp":1625275298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-004-0584-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,30]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1007\/s00262-004-0584-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,30]]}}}